INTRODUCTION
Peroxisomes are virtually ubiquitous organelles of eukaryotic cells that are involved in several metabolic pathways including fatty acid -and -oxidation, the biosynthesis of ether phospholipids and bile salts, and the catabolism of purines, polyamines and L-pipecolic acid [1] . Although the peroxisomal membrane was originally thought to be freely permeable to solutes, various reports demonstrated the existence of peroxisomal transporters in both Saccharomyces cerevisiae and mammalian cells [2] [3] [4] [5] [6] . Moreover, a pH gradient between the cytosol and peroxisomal matrix was shown to exist, indicating that even the transport of protons between these two compartments is regulated [7] [8] [9] . Despite the considerable progress made in peroxisomal solute transport, as mentioned above, the function of many peroxisomal membrane proteins has yet to be determined. Furthermore, some of the already identified peroxisomal transporters are still relatively poorly characterized. For example, except for the yeast Pxa1p/Pxa2p and the human PMP70, which most likely transport long chain acyl-CoA esters, much remains to be determined about transported substrates and mechanisms of other peroxisomal ABC transporters [3] .
Previously known as PMP34, SLC25A17 was first described by Wylin et al.
[10] as a likely counterpart of the Candida boidinii PMP47 and by Honsho and Fujiki [11] as a model peroxisomal membrane protein to investigate topogenic signals. Both these studies demonstrated that SLC25A17 is localized to peroxisomes and belongs to the mitochondrial carrier family [10, 11] , in man known as the SLC25 solute carrier family [12, 13] . Later, SLC25A17 was confirmed to be targeted to peroxisomes and found to possess some unquantified ATP transport activity [14] . Because this latter study reported only the percentage of radioactivity, and not the amount of [ 14 C]ATP taken up by liposomes reconstituted with SLC25A17, and employed a limited set of nucleotides, we set out to perform a more in-depth study on the activity of SLC25A17.
In this study we provide direct evidence that SLC25A17 is a transporter for CoA, FAD and to a lesser extent NAD + . SLC25A17 was expressed in Escherichia coli, purified, reconstituted into liposomes, and shown to transport CoA, FAD, NAD + , adenosine 3',5'-diphosphate (PAP), FMN, AMP and ADP, but not many other compounds. The transporter nearly exclusively catalyzed a counter-exchange of substrates, was saturable and inhibited by pyridoxal-5'-phosphate and other inhibitors; its mRNA was found in all tissues investigated. This is the first time that a carrier for multiple free cofactors has been identified and characterized at the molecular level.
EXPERIMENTAL

Construction of expression plasmid
The coding sequence for SLC25A17 (NM_006358) was amplified from HepG2 cell cDNA by PCR using primers corresponding to the extremities of the coding sequence with additional BamHI and XhoI sites. The amplified product was cloned into the pET-21b expression vector. Transformants of E. coli TOP10 cells were selected on 2X TY (tryptone/yeast extract) plates containing ampicillin (100 μg/ml) and screened by direct colony PCR and restriction digestion of plasmids (1 x TY is 16 g/l tryptone, 10 g/l yeast extract and 5 g/l NaCl, pH 7.4). The sequence of the insert was verified.
Bacterial expression and purification of SLC25A17
SLC25A17 was produced as inclusion bodies in the cytosol of E. coli as described previously [15] , except that the host cells were E. coli strain Rosetta gami B (Novagen). Control cultures with the empty vector were processed in parallel. Inclusion bodies were purified on a sucrose density gradient [15] , washed at 4°C with TE buffer (10 mM Tris/HCl, 1 mM EDTA, pH 6.5), then twice with a buffer containing Triton X-114 (3%, w/v), 1 mM EDTA and 10 mM PIPES NaOH, pH 7.0, and once again with TE buffer. SLC25A17 was solubilized in 1.7% sarkosyl (w/v), and a small residue was removed by centrifugation (258000 x g, 1 h). In some experiments, SLC25A17 with a C-terminal His 6 -tag was purified 3 from S. cerevisiae ant1 cells transformed with a single copy vector containing the SLC25A17-His 6 downstream of the catalase A promoter, exactly as described by Visser et al. [14] .
Reconstitution of SLC25A17 into liposomes and transport assays
The recombinant protein in sarkosyl (N-dodecanoyl-N-methyl-glycine sodium salt) was reconstituted into liposomes in the presence and absence of substrates, as described before [16] . External substrate was removed from proteoliposomes on Sephadex G-75 columns, pre-equilibrated with 50 mM NaCl and 10 mM MOPS-NaOH at pH 7.4 (buffer A). Transport at 25°C was started by adding [ + (Perkin Elmer), FAD, FMN or the indicated substrates to proteoliposomes and terminated by addition of 10 mM pyridoxal-5'-phosphate and 10 mM bathophenanthroline (the "inhibitor stop" method [16] ). In controls, inhibitors were added at the beginning together with the substrate. The external substrate was removed, and the entrapped substrate was measured [16] . The experimental values were corrected by subtracting control values. The initial transport rate was calculated from the substrate taken up by proteoliposomes after 2 min (in the initial linear range of substrate uptake). In some experiments the uptake of 40 μM [ 14 C ]ATP into proteoliposomes loaded with 20 mM ATP was measured after 15 min incubation as described by Visser et al. [14] . For efflux measurements i) proteoliposomes containing 2 mM FAD were passed through Sephadex G-75 to remove the external substrate, and ii) proteoliposomes containing 2 mM AMP were labeled with 5 μM [ 14 C ]AMP by carriermediated exchange equilibration for 40 min [16] and then passed through Sephadex G-75. Efflux was started by adding unlabeled external substrate in buffer A or buffer A alone to aliquots of proteoliposomes and terminated by adding the inhibitors indicated above.
Expression analysis by real-time PCR
FirstChoice
TM total RNAs from human tissues (Ambion) were reverse-transcribed with the GeneAmp RNA PCR Core kit with random hexamers as primers. Real Time PCRs were conducted as described previously [17] using a TaqMan-MGB probe and primers based on the coding sequence of SLC25A17 (Assay ID: Hs00197168_m1, Applied Biosystems). To correct for differences in the amount of starting first-stranded cDNAs, the human peptidylprolyl isomerase A was amplified in parallel as a reference gene.
The SLC25A17 gene was expressed in E. coli Rosetta gami B(DE3) (Fig. 1) . The gene product accumulated as inclusion bodies and was purified on a sucrose discontinuous gradient followed by centrifugation and washing (Figure 1, lane 5) . The identity of the purified protein was confirmed by mass spectrometry analysis of trypsin digests. The protein was not detected in bacteria harvested immediately before induction of expression ( Figure 1, lane 2) , nor in cells harvested after induction but lacking the coding sequence in the expression vector (Figure 1, lane 3) . Approximately 10 mg of purified protein per liter of culture was obtained.
Functional characterization of SLC25A17
The recombinant purified SLC25A17 was reconstituted into liposomes and its transport activity for potential substrates was tested in homo-exchange experiments (i.e. with the same substrate inside and outside). Using external and internal substrate concentrations of 0.1 and 10 mM, respectively, the reconstituted protein catalyzed [ 14 ) and GTP, TTP, CTP, malate, citrate, glutamate, glutamine, ornithine, arginine and Sadenosylmethionine (data not shown). The residual activity in the presence of these compounds was approximately the same as that observed in the presence of NaCl ( Figure  2 ). In addition, no uptake of [ 14 C]AMP into pure liposomes, e.g. without incorporated protein, was observed (data not shown).
In another set of experiments we measured the uptake of the fluorescent FAD and FMN and of the radioactively labeled NAD + and ADP into proteoliposomes in the presence and absence of internal substrate. The results of Given that SLC25A17 (PMP34) was proposed to be an ATP transporter [14] in contrast to the data reported above, we measured the uptake of [ 14 C]ATP in proteoliposomes using the same experimental conditions employed in ref. 14. In these experiments we found an extremely low uptake of [ 14 C]ATP, equal to 0.73 ± 0.2 μmol / 15 min / g protein, into proteoliposomes containing ATP. Therefore, ATP is virtually not transported by SLC25A17.
The effect of inhibitors on the [ 14 C]AMP/AMP exchange reaction catalyzed by reconstituted SLC25A17 was also examined (Figure 4 ). The exchange reaction was inhibited strongly by pyridoxal-5'-phosphate, bathophenanthroline, HgCl 2 and mersalyl, and partially by -cyano-4-cinnamate and p-hydroxymercuribenzoate. In contrast, little effect was observed with N-ethylmaleimide, butylmalonate, 1,2,3-benzenetricarboxylate, carboxyatractyloside and bongkrekic acid, which are known inhibitors of other mitochondrial carriers (Figure 4 ).
Kinetic characteristics of recombinant SLC25A17
In Figure 5A the time-course is compared for the uptake of 1 mM [ 14 C]AMP into reconstituted liposomes measured either as uniport (in the absence of internal substrate) or as exchange (in the presence of one of the indicated substrates). The uptake of figure 5B . In the absence of external substrate a marginal efflux was observed. However, upon addition of external AMP, PAP, CoA or FAD a substantial efflux of radioactivity occurred which was prevented by the inhibitors pyridoxal-5'-phosphate and bathophenanthroline. Also the efflux of fluorescence from proteoliposomes preloaded with FAD was pronounced upon addition of CoA or AMP to the reaction medium, whereas it was much lower and slower upon addition of buffer alone, i.e. in the absence of externally added substrates ( Figure 6 ). In control assays, there was no FAD efflux when transport inhibitors were added at time zero. These results indicate that, at least under the experimental conditions used, reconstituted SLC25A17 functions essentially by a counter-exchange mechanism.
The kinetic constants of recombinant SLC25A17 were determined by measuring the initial transport rate at various external [ 14 C]AMP concentrations in the presence of a fixed saturating internal concentration of 10 mM AMP. The transport affinity (Km) and specific activity (Vmax) values for [ 14 C]AMP/AMP exchange at 25°C were 0.19 ± 0.03 mM and 74 ± 9 μmol/min/g protein, respectively. Several external substrates were competitive inhibitors of [ 14 C]AMP uptake as they increased the apparent Km without changing the Vmax (not shown). The Ki values of these substrates for SLC25A17 were the following: CoA 19.6 ± 3.8 μM, dephospho-CoA 14.4 ± 5.4 μM, FAD 2.6 ± 1.3 μM, FMN 10.2 ± 3.3 μM, NAD + 0.85 ± 0.12 mM, PAP 0.78 ± 0.1 mM and ADP 0.6 ± 0.08 mM.
Expression of the SLC25A17 gene in human tissues
The tissue distribution of SLC25A17 mRNA was determined by real-time PCR. The data of Figure 7 show that the SLC25A17 gene was expressed in all 21 human tissues investigated. This finding is in line with the fact that peroxisomes are present in virtually all eukaryotic cells except in erythrocytes and male germ cells [20] . It should be noted that as post-transcriptional mechanisms may operate, the levels of expression presented in Figure 7 do not necessarily reflect the ratios of transport activities. A c c e p t e d M a n u s c r i p t
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DISCUSSION
In this work, the function of SLC25A17 was investigated by direct transport assays upon expression in E. coli, purification and incorporation of the protein into phospholipid vesicles. The transport properties and kinetic characteristics of recombinant SLC25A17, reported here, unequivocally demonstrate that this protein is a transporter of CoA, FAD and to a lesser extent NAD + . Given that the subcellular localization of SLC25A17 to peroxisomes has been proven by three different groups [10, 11, 14] , this is the first time that a peroxisomal carrier for the free cofactors CoA, FAD and NAD + has been identified from any organism. Of note, the specific activity of reconstituted SLC25A17 is comparable with the activities of other SLC25 proteins [15,17, [14] reported only the percentage of radioactivity without giving numbers, i.e. not the counts of radioactivity per 15 min and the specific radioactivity (counts of radioactivity / 15 min / nmol of [ 14 C]ATP). Therefore, it is impossible to calculate the extent of ATP transport activity from their results [14] . In a phylogenetic tree of H. sapiens, S. cerevisiae and A. thaliana mitochondrial carriers (see Figure 3A of [40] and its homologs At3g05290 and At5g27520 [41] , and the peroxisomal At2g39970 (see below). With all these transporters, except yeast Ant1p and its homologs in Arabidopsis, SLC25A17 shares the distinct feature of having a tryptophan, instead of an acidic residue, in the mitochondrial carrier signature motif PX(D/E)XX(R/K) present in the second repeat of these proteins (see Figure 2 of ref. 13) . Nevertheless, the substrate specificity of SLC25A17 is distinct from that of any other carrier present in the above mentioned cluster, although some overlapping functions (i.e. substrates transported) occur.
During the revision of this manuscript two papers have been published on the closest relative of SLC25A17 in Arabidopsis, i.e. the peroxisomal membrane protein encoded by At2g39970, also known as PMP38. Importantly, in the first paper it was found [42] . In the second paper, in which the APEM3 gene encoding PMP38 was knocked out, the authors concluded that this protein plays an important role in peroxisomal proliferation and stated that they were unable to detect transport of ATP catalyzed by PMP38 [43] . It should be added that PMP38, i.e. At2g39970, was previously found to be incapable of complementing the growth defect of ant1 null strain, whereas At3g05290 and At5g27520 exhibited this ability [41] . It is also interesting to recall that the yeast NAD The closest relative of SLC25A17 in yeast, Ant1p, was found to transport ATP, AMP and ADP with high efficiency and to a lesser extent UDP, UTP, CDP and CTP [40] . Unfortunately, most of the substrates found to be transported by SLC25A17 herein, i.e. FAD, FMN, CoA, NAD + and PAP, were not tested in this early study. However, there are some important sequence differences between SLC25A17 and Ant1p. Apart from the presence of a tryptophan in the signature motif of the second repeat in SLC25A17 and not in Ant1p, both proteins share 26% identical amino acids; this value is too low to draw definite conclusions about the substrate specificity of mitochondrial carrier family members. Furthermore, the residues of the even-numbered transmembrane -helices, which have been proposed to form the similarly located substrate binding site of mitochondrial carriers [44] markedly differ between SLC25A17 (S74 and S78 in H2, L175 and V176 in H4 and Q276 in H6) and Ant1p (A83 and Q87 in H2, L191 and T192 in H4 and K286 in H6). All these differences between SLC25A17 and Ant1p suggest that they may display differences in the substrates they transport. In general, low homology between mitochondrial carriers, as found in the closest relatives of distant organisms, should be regarded with caution when drawing conclusions about their substrate specificity in the absence of direct transport assays involving a wide range of potential substrates. A clear example is provided by the closest S. cerevisiae sequence to the mammalian oxoglutarate carrier, namely the YLR348c gene product, which was identified as the yeast dicarboxylate carrier from its transport characteristics in reconstituted liposomes [45] . Furthermore, disagreement between the predicted and experimentally tested functions of several Arabidopsis mitochondrial carriers has recently been pointed out [13] . Even identified isoforms of mitochondrial carriers with a high percentage of identical amino acids may display clear differences in substrate specificity. For example, ORC1 (i.e. human ornithine carrier 1) transports the L-forms of ornithine, lysine and arginine, whereas ORC2 has a broader specificity also transporting the D-forms of these amino acids as well as histidine and homoarginine, despite the fact that they share 87% identical amino acids [46] . Historically, the first mitochondrial carrier found to be localized in the peroxisomal membrane is PMP47 of Candida boidinii [47] . Nothing is known about the substrate(s) transported by PMP47, although it was speculated to be involved in ATP transport without any direct empirical evidence [48] .
Apart from the relatively low homology that SLC25A17 displays with the transporters discussed above (23-31% identical amino acids), SLC25A17 does not exhibit significant sequence homology with any other known carrier greater than the homology existing among the different members of the mitochondrial carrier family. However, several protein sequences available in databases are likely to be orthologs of SLC25A17 in other organisms. These sequences include: XP_531726.1 from C. familiaris (97% identity), NP_001119741.1 from R. norvegicus (95%), NP_001039413.1 from B. taurus (94%), NP_035529.1 from M. musculus (94%), NP_001088333.1 from X. laevis (73%), NP_001092731.1 from D. rerio (72%), XP_623636.1 from A. mellifera (47%), NP_728982.1 from D. melanogaster (43%), and XP_001662175.1 from A. aegypti (46%). To our knowledge, none of these proteins has been characterized biochemically. Future 3) and with (lanes 2 and 4) the coding sequence of SLC25A17. Samples were taken at the time of induction (lanes 1 and 2) and 4 h later (lanes 3 and 4) . The same number of bacteria was analyzed in each sample. Lane 5, purified SLC25A17 protein (6 μg) derived from bacteria shown in lane 4. 
